Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors From December 2022 to January 2025, one MRT ...
The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials. The move could soon mean more options for patients who need ...
Not all AI is created clinical; Wolters Kluwer experts stress clinician-led development for reliable medication intelligence ...
For decades, pharmacy automation has been defined by what it can do mechanically — count, sort, dispense. Robots fill bins. Barcode systems flag errors. Cabinets track controlled substances. These are ...
This shift aims to turn the traditional, stop-and-go process of drug testing and reporting into a continuous stream of live data. HealthDay News — The US Food and Drug Administration (FDA) is moving ...
The agency announced that it has completed the first tests of a system that allows FDA scientists to see safety and effectiveness data from patients as it is collected, turning the traditional process ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results